XNCR logo

Xencor (XNCR)

Profile

Full Name

Xencor, Inc.

Ticker Symbol

XNCR

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

December 3, 2013

Indexes

Not included

Website

http://www.xencor.com

Employees

250

Key Details

Price

$10.70

Market Cap

$753.94M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$110.49M(-36.72% YoY)

Annual EPS

-$3.58(-62.73% YoY)

PE Ratio

-

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$10.70
XNCR price is $10.70

Price All-time High

$53.88
XNCR price is currently -80.14% below its historical high of $53.88

Price Today Change

-4.72%
XNCR price is down -4.72% today

Price YTD Change

-53.52%
XNCR price is down -53.52% since January 1st

Price 1-year Change

-51.65%
XNCR price is down -51.65% year-on-year

Price 3-year Change

-59.9%
XNCR price is down -59.9% over the past 3 years

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market Cap

$753.94M
XNCR market capitalization is $753.94 million

Market Cap 3-year Change

-52.53%
XNCR market capitalization is down -52.53% over the past 3 years

Market Cap All-time High

$3.12B
XNCR market capitalization is currently -75.82% below its historical high of $3.12 billion

Market Cap Sector Rank

72.98%
XNCR market capitalization is higher than 72.98% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+15.26%
XNCR shares outstanding is up +15.26% year-on-year

Shares Outstanding 3-Year Change

+18.67%
XNCR shares outstanding is up +18.67% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.28
XNCR beta is 1.28

200-day SMA

$19.57
XNCR price is currently -45.32% below its 200-day simple moving average

50-day SMA

$15.64
XNCR price is currently -31.57% below its 50-day simple moving average

RSI

26.13
XNCR 14-day relative strength index is 26.13

Volume

0.95
XNCR 30-day relative volume is 0.95

ATR

$0.67
XNCR average true range is $0.67

10-day Historical Volatility

68.68%
XNCR 10-day historical volatility is 68.68%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$110.49M
XNCR annual revenue is $110.49 million

Revenue Analysts Estimate

$105.70M
XNCR annual revenue is currently +4.54% higher than the consensus analysts' forecast

Revenue 1-year Change

-36.72%
XNCR annual revenue is down -36.72% year-on-year

Revenue Sector Rank

57.24%
XNCR annual revenue is higher than 57.24% of companies in Healthcare sector

EPS

EPS

-$3.58
XNCR annual earnings per share is -$3.58

EPS Analysts Estimate

-$2.63
XNCR annual earnings per share is currently +36.37% higher than the consensus analysts' forecast

EPS 1-year Change

-62.73%
XNCR annual earnings per share is down -62.73% year-on-year

EPS Sector Rank

25.64%
XNCR annual earnings per share is higher than 25.64% of companies in Healthcare sector

Profit

Gross Profit

-
XNCR annual gross profit value is unknown

Gross Margin

-
XNCR annual gross profit margin value is unknown

Operating Profit

-$178.41M
XNCR annual operating income is -$178.41 million

Operating Margin

-161.47%
XNCR annual operating profit margin is -161.47%

Net Income

-$232.62M
XNCR annual net profit is -$232.62 million

Net Margin

-210.53%
XNCR annual net profit margin is -210.53%

Expenses

Total Expenses

$288.90M
XNCR annual total expenses is $288.90 million

Operating Expenses

$288.90M
XNCR annual total operating expenses is $288.90 million

Cost Of Goods Sold

-
XNCR annual cost of goods sold value is unknown

Selling, General & Administrative Expenses

$61.22M
XNCR annual SGA is $61.22 million

Depreciation And Amortization

$12.11M
XNCR annual depreciation & amortization is $12.11 million

Interest Expense

$36.64M
XNCR annual interest expense is $36.64 million

Income Tax

$1.62M
XNCR annual income tax is $1.62 million

EBIT & EBITDA

EBIT

-$198.28M
XNCR annual earnings before interest & taxes is -$198.28 million

EBITDA

-$186.17M
XNCR annual EBITDA is -$186.17 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total Assets

$951.95M
XNCR annual total assets is $951.95 million

Non Current Assets

$374.34M
XNCR annual long term assets is $374.34 million

Current Assets

$577.60M
XNCR annual total current assets is $577.60 million

Cash And Cash Equivalents

$40.88M
XNCR annual cash & cash equivalents is $40.88 million

Accounts Receivable

$60.85M
XNCR annual accounts receivable is $60.85 million

Inventory

-
XNCR annual inventory value is unknown

Liabilities

Total Liabilities

$277.92M
XNCR annual total liabilities is $277.92 million

Long Term Liabilities

$190.49M
XNCR annual total long term liabilities is $190.49 million

Current Liabilities

$87.43M
XNCR annual total current liabilities is $87.43 million

Accounts Payable

$16.76M
XNCR annual accounts payable is $16.76 million

Debt

Total Debt

$231.95M
XNCR annual total debt is $231.95 million

Total Debt 1-year Change

-7.93%
XNCR annual total debt is down -7.93% year-on-year

Long Term Debt

$180.50M
XNCR annual long term debt is $180.50 million

Short Term Debt

$51.46M
XNCR annual short term debt is $51.46 million

Equity & Capital

Shareholders Equity

$677.61M
XNCR annual stockholders equity is $677.61 million

Book Value

$677.61M
XNCR annual book value is $677.61 million

Retained Earnings

-$704.04M
XNCR annual retained earnings is -$704.04 million

Working Capital

$490.17M
XNCR annual working capital is $490.17 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash From Operations

-$202.19M
XNCR annual cash flow from operations is -$202.19 million

Cash From Operations 1-year Change

-159.46%
XNCR annual cash flow from operations is down -159.46% year-on-year

Cash From Investing

-$7.87M
XNCR annual cash flow from investing activities is -$7.87 million

Cash From Investing 1-year Change

+92.91%
XNCR annual cash flow from investing activities is up +92.91% year-on-year

Cash From Financing

$197.15M
XNCR annual cash flow from financing activities is $197.15 million

Cash From Financing 1-year Change

+4.19%
XNCR annual cash flow from financing activities is up +4.19% year-on-year

CAPEX

CAPEX

$9.51M
XNCR annual capital expenditures is $9.51 million

CAPEX 1-year Change

-55.24%
XNCR annual capital expenditures is down -55.24% year-on-year

Free Cash Flow

Free Cash Flow

-$211.70M
XNCR annual free cash flow is -$211.70 million

Free Cash Flow 1-year Change

-113.46%
XNCR annual free cash flow is down -113.46% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross Margin

-
XNCR annual gross profit margin value is unknown

Operating Margin

-161.47%
XNCR annual operating profit margin is -161.47%

Net Margin

-210.53%
XNCR annual net profit margin is -210.53%

ROA & ROE

ROA

-24.27%
XNCR annual return on assets is -24.27%

ROE

-34.82%
XNCR annual return on equity is -34.82%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
XNCR price to earnings ratio value is unknown

PE Ratio Sector Rank

-
XNCR price to earnings ratio is unknown

PB Ratio

PB Ratio

1.11
XNCR price to book ratio is 1.11

PB Ratio Sector Rank

46.4%
XNCR price to book ratio is higher than 46.4% of companies in Healthcare sector

PS Ratio

PS Ratio

6.82
XNCR price to sales ratio is 6.82

PS Ratio Sector Rank

72.34%
XNCR price to sales ratio is higher than 72.34% of companies in Healthcare sector

Enterprise value

Enterprise Value

$945.02M
XNCR enterprise value is $945.02 million

Enterprise Value Sector Rank

74.46%
XNCR enterprise value is higher than 74.46% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-5.08
XNCR EV/EBITDA is -5.08

EV/EBITDA Sector Rank

19.41%
XNCR EV/EBITDA is higher than 19.41% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current Ratio

6.61
XNCR annual current ratio is 6.61

Quick Ratio

-
XNCR annual quick ratio value is unknown

Leverage

Debt To Equity

0.24
XNCR annual debt to equity ratio is 0.24

Interest Coverage Ratio

-5.41
XNCR annual interest coverage ratio is -5.41

Risk & Stability

Piotroski F-Score

-
XNCR piotroski f-score value is unknown

Altman Z-Score

0.64
XNCR altman z-score is 0.64

Analyst ratings

Recent major analysts updates

Feb 28, 25 Wells Fargo
Overweight
Dec 12, 24 Wells Fargo
Overweight
Dec 2, 24 Piper Sandler
Overweight
Nov 8, 24 BMO Capital
Outperform
Nov 7, 24 JP Morgan
Overweight
Sep 26, 24 RBC Capital
Outperform
Aug 6, 24 RBC Capital
Outperform
Aug 6, 24 BMO Capital
Outperform
Jul 31, 24 JP Morgan
Overweight
Jun 14, 24 Raymond James
Strong Buy

Institutional Ownership

Similar stocks

HCSG logo
Healthcare Services (HCSG)
PRAX logo
Praxis Precision Medicines (PRAX)
EMBC logo
Embecta (EMBC)
COGT logo
Cogent Biosciences (COGT)
Fortrea Holdings (FTRE)
AXGN logo
AxoGen (AXGN)
WEAV logo
Weave Communications (WEAV)
AVXL logo
Anavex Life Sciences (AVXL)
CRON logo
Cronos (CRON)
  • What is the ticker symbol for Xencor?
  • Does Xencor pay dividends?
  • What sector is Xencor in?
  • What industry is Xencor in?
  • What country is Xencor based in?
  • When did Xencor go public?
  • Is Xencor in the S&P 500?
  • Is Xencor in the NASDAQ 100?
  • Is Xencor in the Dow Jones?
  • When was Xencor's last earnings report?
  • When does Xencor report earnings?
  • Should I buy Xencor stock now?

What is the ticker symbol for Xencor?

The ticker symbol for Xencor is NASDAQ:XNCR

Does Xencor pay dividends?

No, Xencor does not pay dividends

What sector is Xencor in?

Xencor is in the Healthcare sector

What industry is Xencor in?

Xencor is in the Biotechnology industry

What country is Xencor based in?

Xencor is headquartered in United States

When did Xencor go public?

Xencor's initial public offering (IPO) was on December 3, 2013

Is Xencor in the S&P 500?

No, Xencor is not included in the S&P 500 index

Is Xencor in the NASDAQ 100?

No, Xencor is not included in the NASDAQ 100 index

Is Xencor in the Dow Jones?

No, Xencor is not included in the Dow Jones index

When was Xencor's last earnings report?

Xencor's most recent earnings report was on Feb 27, 2025

When does Xencor report earnings?

The next expected earnings date for Xencor is May 9, 2025

Should I buy Xencor stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page